Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | FEN1 | P39748 | 11/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 8/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15834804 | 0.90 | ALDH1A1 (0.44) | ALDH1A1FEN1ALOX5APESR1ESR2 | |
| SCHEMBL12826470 | 0.90 | KCNA3 (0.39) | FEN1ALOX5APESR1ESR2PTPRC | |
| SCHEMBL23919514 | 0.89 | ALDH1A1 (0.44) | ALDH1A1FEN1ALOX5APESR1ESR2 | |
| SCHEMBL13412052 | 0.89 | FEN1 (0.39) | ALDH1A1FEN1ALOX5APESR1ESR2 | |
| SCHEMBL18785322 | 0.87 | NFE2L2 (0.37) | ALDH1A1FEN1ALOX5APESR1ESR2 | |
| SCHEMBL13412049 | 0.87 | FEN1 (0.38) | ALDH1A1FEN1ALOX5APESR1ESR2 | |
| SCHEMBL12826297 | 0.86 | KCNA3 (0.39) | FEN1ALOX5APESR1ESR2PTPRC | |
| SCHEMBL27834100 | 0.85 | PDE3B (0.40) | ALDH1A1FEN1ALOX5APCYP3A4 | |
| SCHEMBL1942123 | 0.85 | TSHR (0.43) | ALDH1A1FEN1ALOX5APESR1PTPRC | |
| SCHEMBL11671603 | 0.85 | PPARG (0.45) | ALDH1A1APPCYP3A4CYP2C19CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011773-B2 | Liquid crystal display device | DIC CORPORATION (JP) | 2018-07-03 | — | — | US | disclosed |
| US-20180100105-A1 | ANISOTROPIC SCATTERING FILM | DIC CORPORATION (JP) | 2018-04-12 | — | — | US | disclosed |
| US-9828548-B2 | Liquid-crystal composition | DIC CORPORATION (JP) | 2017-11-28 | — | — | US | disclosed |
| US-9809752-B2 | Liquid crystal display device | DIC CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9771517-B2 | Liquid-crystal optical modulation element | DIC CORPORATION (JP) | 2017-09-26 | — | — | US | disclosed |
| US-9410086-B2 | Liquid crystal-polymer composite material | DIC CORPORATION (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20160215217-A1 | LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2016-07-28 | — | — | US | disclosed |
| US-20160194561-A1 | DIFLUOROPHENYL LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160130502-A1 | LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2016-05-12 | — | — | US | disclosed |
| US-20160017226-A1 | LIQUID-CRYSTAL OPTICAL MODULATION ELEMENT | DIC CORPORATION (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20150259600-A1 | LIQUID-CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2015-09-17 | — | — | US | disclosed |
| US-20150166893-A1 | LIQUID CRYSTAL-POLYMER COMPOSITE MATERIAL | DIC Corporation (Tokyo) (JP) | 2015-06-18 | — | — | US | disclosed |
| US-8992796-B2 | Polymerizable liquid crystal composition | DIC CORPORATION (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20140327862-A1 | FERROELECTRIC LIQUID CRYSTAL COMPOSITION AND FERROELECTRIC LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140313468-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2014-10-23 | — | — | US | disclosed |
| US-8405799-B2 | Polymer-stabilized liquid crystal composition, liquid crystal display device, method for producing liquid crystal display device | DIC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20120056129-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2012-03-08 | — | — | US | disclosed |
| US-7871540-B2 | Polymerizable liquid crystal composition | DIC CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20100149446-A1 | POLYMER-STABILIZED LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE, METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090050844-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION | H1-0, H1-4, H1-10 | ALDH1A1 4147/4885FEN1 3191/4885ALOX5AP 3234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.